Associated Papers
Genetic polymorphism of pharmacogenomic VIP variants in the Deng people from the Himalayas in Southeast Tibet.
Shi X et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals, 2015
β-adrenergic receptor polymorphisms in susceptibility, response to treatment and prognosis in heart failure: implication of ethnicity.
Pereira SB et al.
Molecular Medicine Reports, 2013
Pharmacogenetics in heart failure: promises and challenges.
de Boer RA et al.
Expert Opinion on Pharmacotherapy, 2009
Impact of GPCRs in clinical medicine: monogenic diseases, genetic variants and drug targets.
Insel PA et al.
Biochimica Et Biophysica Acta, 2007
Pharmacogenetics, pharmacogenomics and airway disease.
Hall IP
Respiratory Research, 2002
Pharmacogenetics in the practice of laboratory medicine.
Linder MW et al.
Molecular Diagnosis : a Journal Devoted to the Understanding of Human Disease Through the Clinical Application of Molecular Biology, 1999
Population frequency, mutation linkage and analytical methodology for the Arg16Gly, Gln27Glu and Thr164Ile polymorphisms in the beta2-adrenergic receptor among Turks.
Aynacioglu AS et al.
British Journal of Clinical Pharmacology, 1999
Select a paper to view details